These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21997588)

  • 1. Diagnostic efficiency of the cochlear hydrops analysis masking procedure in Ménière's disease.
    Lee JB; Choi SJ; Park K; Park HY; Hong JJ; Hwang E; Lee HJ; Kim CH; Choung YH
    Otol Neurotol; 2011 Dec; 32(9):1486-91. PubMed ID: 21997588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of cochlear hydrops analysis masking procedure in patients with Meniere's disease and otologically normal adults.
    Shang YY; Diao WW; Ni DF; Gao ZQ; Xu CX; Li FR
    Chin Med J (Engl); 2012 Dec; 125(24):4449-53. PubMed ID: 23253718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical observation on acute low-frequency hearing loss without vertigo: the role of cochlear hydrops analysis masking procedure as initial prognostic parameter.
    Hong SK; Nam SW; Lee HJ; Koo JW; Kim DH; Kim DR; Kim H
    Ear Hear; 2013; 34(2):229-35. PubMed ID: 22976344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of diagnostic value of high-pass noise masking of auditory brainstem responses in Ménière's disease.
    De Valck CF; Claes GM; Wuyts FL; Van de Heyning PH
    Otol Neurotol; 2007 Aug; 28(5):700-7. PubMed ID: 17667775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of electrocochleography and high-pass noise masking of auditory brainstem response for diagnosis of Ménière's disease.
    Zack-Williams D; Angelo RM; Yue Q
    Int J Audiol; 2012 Oct; 51(10):783-7. PubMed ID: 22809268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three methods of using transtympanic electrocochleography for the diagnosis of Meniere's disease: click summating potential measurements, tone burst summating potential amplitude measurements, and biasing of the summating potential using a low frequency tone.
    Iseli C; Gibson W
    Acta Otolaryngol; 2010; 130(1):95-101. PubMed ID: 19396716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic test validation: cochlear hydrops analysis masking procedure in Ménière's disease.
    Ordóñez-Ordóñez LE; Rojas-Roncancio E; Hernández-Alarcón V; Jaramillo-Safón R; Prieto-Rivera J; Guzmán-Durán J; Lora-Falquez J; Escobar M; Angulo-Martínez ES
    Otol Neurotol; 2009 Sep; 30(6):820-5. PubMed ID: 19638943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summating potential-action potential waveform amplitude and width in the diagnosis of Menière's disease.
    Ikino CM; de Almeida ER
    Laryngoscope; 2006 Oct; 116(10):1766-9. PubMed ID: 17003737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ménière's Disease Index: an objective correlate of Ménière's disease, based on audiometric and electrocochleographic data.
    Claes GM; De Valck CF; Van de Heyning P; Wuyts FL
    Otol Neurotol; 2011 Jul; 32(5):887-92. PubMed ID: 21512426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochlear hydrops analysis masking procedure results in patients with unilateral Ménière's disease.
    Kingma CM; Wit HP
    Otol Neurotol; 2010 Aug; 31(6):1004-8. PubMed ID: 20684065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplitude and area ratios of summating potential/action potential (SP/AP) in Meniere's disease.
    Baba A; Takasaki K; Tanaka F; Tsukasaki N; Kumagami H; Takahashi H
    Acta Otolaryngol; 2009 Jan; 129(1):25-9. PubMed ID: 19003588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochlear microphonics in Ménière's disease.
    Ge NN; Shea JJ; Orchik DJ
    Am J Otol; 1997 Jan; 18(1):58-66. PubMed ID: 8989953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report.
    Adamonis J; Stanton SG; Cashman MZ; Mattan K; Nedzelski JM; Chen JM
    Am J Otol; 2000 Jul; 21(4):534-42. PubMed ID: 10912700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hearing loss, age, and gender on the outcome of the cochlear hydrops analysis masking procedure.
    Kim BJ; Jung SD; Lee HJ; Jung JY; Suh MW
    Otol Neurotol; 2015 Mar; 36(3):472-5. PubMed ID: 25502455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of vestibular Menière's disease with electrocochleography.
    Dornhoffer JL; Arenberg IK
    Am J Otol; 1993 Mar; 14(2):161-4. PubMed ID: 8503490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative diagnostic test for active Ménière's disease and cochlear hydrops using high-pass noise masked responses: the complex amplitude ratio.
    Don M; Kwong B; Tanaka C
    Audiol Neurootol; 2007; 12(6):359-70. PubMed ID: 17664867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we use electrocochleography as a clinical tool in the diagnosis of Meniere's disease during the early symptomatic period?
    Oh KH; Kim KW; Chang J; Jun HS; Kwon EH; Choi JY; Im GJ; Chae SW; Jung HH; Choi J
    Acta Otolaryngol; 2014 Aug; 134(8):771-5. PubMed ID: 24865301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vestibular evoked myogenic potentials and glycerol testing.
    Magliulo G; Cuiuli G; Gagliardi M; Ciniglio-Appiani G; D'Amico R
    Laryngoscope; 2004 Feb; 114(2):338-43. PubMed ID: 14755215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.